Truvestments Capital’s Hologic HOLX Stock Holding History

Truvestments Capital’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-36	Closed	-$2.69K	–	810
2022 Q4	$2.69K	Buy	+36	New	+$2.56K	﹤0.01%	671

Other funds holding HOLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Truvestments Capital's HOLX Position: Q1 2023 in Review

Truvestments Capital sold out of Hologic (HOLX) in Q1 2023, closing a stake of 36 shares — an estimated $2.69K sold.

Truvestments Capital first reported a position in HOLX in Q4 2022 and held it in 1 quarter. The position peaked at $2.69K in Q4 2022. 708 funds tracked by Wall St. Rank hold HOLX as of Q1 2023.

Truvestments Capital reported no remaining Hologic position as of Q1 2023 after selling out during the quarter.
Truvestments Capital sold 36 Hologic shares in Q1 2023, an estimated $2.69K.
Truvestments Capital first reported a position in Hologic in Q4 2022 and held it in 1 quarter.
Truvestments Capital's Hologic position peaked at $2.69K in Q4 2022.
708 funds tracked by Wall St. Rank held Hologic as of Q1 2023.

Based on Truvestments Capital's 13F filing for Q1 2023, filed 12 May 2023.